Lane S S, Kopietz L A, Lindquist T D, Leavenworth N
Department of Ophthalmology, University of Minnesota, Minneapolis.
Ophthalmology. 1988 Jun;95(6):749-53. doi: 10.1016/s0161-6420(88)33113-1.
The treatment of choice for phacolytic glaucoma has been intracapsular cataract extraction (ICCE). The current study was undertaken to determine the efficacy of extracapsular cataract extraction (ECCE) as a definitive treatment for phacolytic glaucoma. Five cases of phacolytic glaucoma that occurred between 1984 and 1986 were studied after a retrospective chart review; ECCE (with placement of a posterior chamber intraocular lens [PC IOL]) was performed without complication and was curative in all five eyes. All patients (100%) maintained intraocular pressures (IOPs) of less than 20 mmHg, without medical therapy. The best-corrected visual acuity for all cases was 20/50 or better (80%, greater than or equal to 20/40) with 5 months to 3 years follow-up. These results suggest that ECCE is an effective alternative for the treatment of phacolytic glaucoma and allows surgeons the freedom to choose the procedure with which they are most comfortable. Additionally, implantation of a PC IOL is a safe and efficacious procedure in restoring visual function in these patients.
晶状体溶解性青光眼的首选治疗方法一直是囊内白内障摘除术（ICCE）。本研究旨在确定囊外白内障摘除术（ECCE）作为晶状体溶解性青光眼的最终治疗方法的疗效。通过回顾性病历审查，对1984年至1986年间发生的5例晶状体溶解性青光眼病例进行了研究；进行了ECCE（植入后房型人工晶状体[PC IOL]），无并发症发生，且所有5只眼均治愈。所有患者（100%）在未接受药物治疗的情况下眼压（IOP）维持在20 mmHg以下。随访5个月至3年，所有病例的最佳矫正视力均为20/50或更好（80%，大于或等于20/40）。这些结果表明，ECCE是治疗晶状体溶解性青光眼的一种有效替代方法，使外科医生能够自由选择他们最熟悉的手术方式。此外，植入PC IOL在恢复这些患者的视觉功能方面是一种安全有效的手术。
